MICHELLE MERCIER: Open Payments
NPI 1134601552 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$590 in 32 payments from 13 companies in 2025. Trend: 2023 $136 · 2024 $219 · 2025 $590
Food & beverage: $578Education: $12
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 7 | $138 |
| Axsome Therapeutics, Inc. | 5 | $91 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $82 |
| Otsuka America Pharmaceutical, Inc. | 3 | $59 |
| Janssen Pharmaceuticals, Inc | 2 | $38 |
| E.R. Squibb & Sons, L.L.C. | 2 | $38 |
| Noven Therapeutics, LLC | 2 | $34 |
| Lundbeck LLC | 1 | $21 |
| Corium, LLC | 2 | $20 |
| ABBVIE INC. | 1 | $19 |
Products named: FANAPT, Auvelity, CAPLYTA, REXULTI, COBENFY, Secuado, ABILIFY MAINTENA, SPRAVATO.
Industry payments across IN — which companies pay providers there.
